Our first General Assembly will take place at the National Rare Deseases Platform in Paris on December 7 at 6 pm. Dr Marc-Henri Bourdon will make a presentation of the studies he has been undertaking for more the 25 years with his team on the MED13 and MED13L genes. His conference will be also available by videoconference for the members.
